Skip to main content
Caplight Logo









ABCDx

ABCDx

Private
Plan-les-OuatesHealthcare & Life Scienceshttps://www.abcdx.ch/

Last Round

Series A

Oct 18, 2023

Total Funding Raised

$2.46M

Company Overview

ABCDx is a medtech company that develops point-of-care diagnostic tools for brain injuries, including stroke and traumatic brain injury, using blood-based biomarkers.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting, Hardware Sales

AI Layer

Application

Keywords

point-of-care diagnosticsPOC diagnosticsSoftware as a Medical DeviceSaMDmedical AIbrain injury diagnosticsstroke triagebiomarker technologyclinical decision supportdigital healthmedtechpre-hospital careemergency medical servicesEMSdiagnostic software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ABCDx Comparables

Compare ABCDx with similar companies based on industry and business-model similarity.

ABCDx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Upfront Diagnostics
88%
Forest Devices
80%
NanoDx
78%

ABCDx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AOct 18, 2023
GrantOct 1, 2022
SeedDec 17, 2021
SeedJul 1, 2018

Key People

Founding team and executive leadership

jean-charles sanchez

CEO

Executive Team

ABCDx Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 20, 2024

    Grew 33% QoQ, from 9 to 12 employees.

  • Oct 18, 2023

    Completed a Series A funding round.

ABCDx Filings

Explore SEC and related filing metadata, where available.

ABCDx filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ABCDx's valuation, stock price, and market status.

Is ABCDx a public or private company?

ABCDx is a private company.

What is the current stock price of ABCDx?

ABCDx is a private company with no public stock price. No recent secondary market data is available.

How much is ABCDx worth (valuation)?

Valuation information for ABCDx is not publicly available.

Can I buy ABCDx stock?

ABCDx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ABCDx's last funding round?

ABCDx's most recent funding round was Series A on October 18, 2023.

Who are the main investors in ABCDx?

Key investors in ABCDx include Eurostars SME programme, Venture Kick.

Will ABCDx IPO soon?

No public IPO plans have been announced for ABCDx.

How can I track ABCDx secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ABCDx's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPlan-les-Ouates
Employee Range15
Year Founded2014
Last FundingOct 18, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?